{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:53:59Z","timestamp":1790996039913,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Although excessive dietary sodium intake is a well-recognized risk factor for hypertension, accumulating evidence indicates that it leads to broader metabolic consequences. Here, we investigated the renal and skeletal consequences of high salt loading and the protective effects of esaxerenone, a selective nonsteroidal mineralocorticoid receptor (MR) antagonist. Male Sprague-Dawley rats were infused with aldosterone and fed an 8% sodium chloride diet for 4 weeks (Aldo-HS), with or without esaxerenone. Trabecular bone architecture was assessed by micro-computed tomography, three-dimensional morphometry, and histomorphometry. Kidney and bone transcriptomes were analyzed using RNA sequencing and weighted gene co-expression network analysis. Aldo-HS rats developed marked renal calcium wasting without changes in serum calcium, phosphate, parathyroid hormone, or fibroblast growth factor 23 levels. Fractional calcium excretion was strongly inversely correlated with trabecular bone volume (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u2009\u20130.74,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Aldosterone\u2013salt loading induced substantial trabecular bone loss, which was prevented by esaxerenone. Bone transcriptomic analysis demonstrated suppression of extracellular matrix gene programs; a collagen-enriched gene module (including\n                    <jats:italic>Col1a1<\/jats:italic>\n                    ,\n                    <jats:italic>Col1a2<\/jats:italic>\n                    ,\n                    <jats:italic>Col11a1<\/jats:italic>\n                    ) was tightly linked to calcium wasting (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u2009\u20130.97,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), partially restored by MR blockade, and overlapped with loci associated with bone mineral density in human genome-wide association studies. Aldosterone\u2013salt loading induces trabecular bone loss accompanied by imbalance in bone remodeling and renal calcium wasting. MR blockade preserves skeletal integrity, supporting a modifiable bone\u2013kidney axis and providing translational insight into skeletal complications of mineralocorticoid excess.\n                  <\/jats:p>","DOI":"10.1038\/s41440-026-02832-0","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:15:41Z","timestamp":1790932541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated morphological and transcriptomic analysis of bone disorders in aldosterone-salt hypertension"],"prefix":"10.1038","author":[{"given":"Mika","family":"Kawagoe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigoro","family":"Hirohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifuru","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"2832_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/bmj.297.6644.319","volume":"297","author":"Results for 24 h urinary sodium and potassium excretion. Intersalt Cooperative Research Group","year":"1988","unstructured":"Intersalt: an international study of electrolyte excretion and blood pressureResults for 24h urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ. 1988;297:319\u201328.","journal-title":"BMJ"},{"key":"2832_CR2","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1073\/pnas.1713837115","volume":"115","author":"MA Lanaspa","year":"2018","unstructured":"Lanaspa MA, Kuwabara M, Andres-Hernando A, Li N, Cicerchi C, Jensen T, et al. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc Natl Acad Sci USA. 2018;115:3138\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2832_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2337\/diabetes.50.3.573","volume":"50","author":"T Ogihara","year":"2001","unstructured":"Ogihara T, Asano T, Ando K, Chiba Y, Sekine N, Sakoda H, et al. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes. 2001;50:573\u201383.","journal-title":"Diabetes"},{"key":"2832_CR4","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1017\/S0007114514003833","volume":"113","author":"Z Ge","year":"2015","unstructured":"Ge Z, Guo X, Chen X, Tang J, Yan L, Ren J, et al. Association between 24 h urinary sodium and potassium excretion and the metabolic syndrome in Chinese adults: the Shandong and Ministry of Health Action on Salt and Hypertension (SMASH) study. Br J Nutr. 2015;113:996\u20131002.","journal-title":"Br J Nutr"},{"key":"2832_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2020.537049","volume":"7","author":"T Abdulai","year":"2020","unstructured":"Abdulai T, Runqi T, Mao Z, Oppong TB, Amponsem-Boateng C, Wang Y, et al. Preference for high dietary salt intake is associated with undiagnosed type 2 diabetes: the Henan rural cohort. Front Nutr. 2020;7:537049.","journal-title":"Front Nutr"},{"key":"2832_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2025.102145","volume":"31","author":"S Zhu","year":"2025","unstructured":"Zhu S, Liu L, Shen Y, Li R, Lin J, Liu L, et al. Different measures of sodium intake and the risk of metabolic dysfunction-associated steatotic liver disease: Evidence from the UK Biobank. Ann Hepatol. 2025;31:102145.","journal-title":"Ann Hepatol"},{"key":"2832_CR7","doi-asserted-by":"crossref","unstructured":"Yoshida Y, Kosaki K, Sugasawa T, Matsui M, Yoshioka M, Aoki K, et al. High salt diet impacts the risk of sarcopenia associated with reduction of skeletal muscle performance in the Japanese population. Nutrients. 2020;12:3474.","DOI":"10.3390\/nu12113474"},{"key":"2832_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/HYPERTENSIONAHA.121.16495","volume":"78","author":"F Elijovich","year":"2021","unstructured":"Elijovich F, Kleyman TR, Laffer CL, Kirabo A. Immune mechanisms of dietary salt-induced hypertension and kidney disease: Harry Goldblatt award for early career investigators 2020. Hypertension. 2021;78:252\u201360.","journal-title":"Hypertension"},{"key":"2832_CR9","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMra2030212","volume":"385","author":"DH Ellison","year":"2021","unstructured":"Ellison DH, Welling P. Insights into salt handling and blood pressure. N Engl J Med. 2021;385:1981\u201393.","journal-title":"N Engl J Med"},{"key":"2832_CR10","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1007\/s00198-017-4050-z","volume":"28","author":"C Li","year":"2017","unstructured":"Li C, Zeng Y, Tao L, Liu S, Ni Z, Huang Q, et al. Meta-analysis of hypertension and osteoporotic fracture risk in women and men. Osteoporos Int. 2017;28:2309\u201318.","journal-title":"Osteoporos Int"},{"key":"2832_CR11","doi-asserted-by":"publisher","first-page":"68916","DOI":"10.18632\/oncotarget.20325","volume":"8","author":"Z Ye","year":"2017","unstructured":"Ye Z, Lu H, Liu P. Association between essential hypertension and bone mineral density: a systematic review and meta-analysis. Oncotarget. 2017;8:68916\u201327.","journal-title":"Oncotarget"},{"key":"2832_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.kisu.2021.11.006","volume":"12","author":"JM Luther","year":"2022","unstructured":"Luther JM, Fogo AB. The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis. Kidney Int Suppl (2011). 2022;12:63\u20138.","journal-title":"Kidney Int Suppl (2011)"},{"key":"2832_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/hr.2016.137","volume":"40","author":"S Shibata","year":"2017","unstructured":"Shibata S, Ishizawa K, Uchida S. Mineralocorticoid receptor as a therapeutic target in chronic kidney disease and hypertension. Hypertens Res. 2017;40:221\u20135.","journal-title":"Hypertens Res"},{"key":"2832_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709\u201317.","journal-title":"N Engl J Med"},{"key":"2832_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309\u201321.","journal-title":"N Engl J Med"},{"key":"2832_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364:11\u201321.","journal-title":"N Engl J Med"},{"key":"2832_CR17","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219\u201329.","journal-title":"N Engl J Med"},{"key":"2832_CR18","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","volume":"385","author":"B Pitt","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021;385:2252\u201363.","journal-title":"N Engl J Med"},{"key":"2832_CR19","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","volume":"2","author":"K Ando","year":"2014","unstructured":"Ando K, Ohtsu H, Uchida S, Kaname S, Arakawa Y, Fujita T. Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial. Lancet Diab Endocrinol. 2014;2:944\u201353.","journal-title":"Lancet Diab Endocrinol"},{"key":"2832_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.574151","volume":"11","author":"S Shi","year":"2020","unstructured":"Shi S, Lu C, Tian H, Ren Y, Chen T. Primary aldosteronism and bone metabolism: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:574151.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2832_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41371-018-0069-7","volume":"32","author":"X Shu","year":"2018","unstructured":"Shu X, Mei M, Ma L, Wang Z, Yang S, Hu J, et al. Postmenopausal osteoporosis is associated with elevated aldosterone\/renin ratio. J Hum Hypertens. 2018;32:524\u201330.","journal-title":"J Hum Hypertens"},{"key":"2832_CR22","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00198-024-07132-2","volume":"35","author":"E Gkaniatsa","year":"2024","unstructured":"Gkaniatsa E, Sandstr\u00f6m TZ, Rosengren A, Trimpou P, Muth A, Johannsson G, et al. Hip fractures in patients with primary aldosteronism - a Swedish nationwide study. Osteoporos Int. 2024;35:1585\u201393.","journal-title":"Osteoporos Int"},{"key":"2832_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jacc.2005.03.055","volume":"46","author":"PH Law","year":"2005","unstructured":"Law PH, Sun Y, Bhattacharya SK, Chhokar VS, Weber KT. Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol. 2005;46:142\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"2832_CR24","doi-asserted-by":"publisher","first-page":"K47","DOI":"10.1093\/ejendo\/lvae020","volume":"190","author":"H Schneider","year":"2024","unstructured":"Schneider H, Br\u00fcdgam D, Nowotny HF, Schmidmaier R, Reincke M, Adolf C. Moderate salt restriction in primary aldosteronism improves bone metabolism through attenuation of urinary calcium and phosphate losses. Eur J Endocrinol. 2024;190:K47\u2013k52.","journal-title":"Eur J Endocrinol"},{"key":"2832_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s42003-020-01298-1","volume":"3","author":"Q Wang","year":"2020","unstructured":"Wang Q, Ishizawa K, Li J, Fujii W, Nemoto Y, Yamazaki O, et al. Urinary phosphate-containing nanoparticle contributes to inflammation and kidney injury in a salt-sensitive hypertension rat model. Commun Biol. 2020;3:575.","journal-title":"Commun Biol"},{"key":"2832_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1056\/NEJM199002013220502","volume":"322","author":"AZ LaCroix","year":"1990","unstructured":"LaCroix AZ, Wienpahl J, White LR, Wallace RB, Scherr PA, George LK, et al. Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med. 1990;322:286\u201390.","journal-title":"N Engl J Med"},{"key":"2832_CR27","volume":"6","author":"LC Desbiens","year":"2022","unstructured":"Desbiens LC, Khelifi N, Wang YP, Lavigne F, Beaulieu V, Sidib\u00e9 A, et al. Thiazide diuretics and fracture risk: a systematic review and meta-analysis of randomized clinical trials. JBMR Plus. 2022;6:e10683.","journal-title":"JBMR"},{"key":"2832_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1161\/HYPERTENSIONAHA.116.08519","volume":"69","author":"N Xu","year":"2017","unstructured":"Xu N, Hirohama D, Ishizawa K, Chang WX, Shimosawa T, Fujita T, et al. Hypokalemia and pendrin induction by aldosterone. Hypertension. 2017;69:855\u201362.","journal-title":"Hypertension"},{"key":"2832_CR29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/s41440-021-00710-5","volume":"44","author":"F Ochiai-Homma","year":"2021","unstructured":"Ochiai-Homma F, Kuribayashi-Okuma E, Tsurutani Y, Ishizawa K, Fujii W, Odajima K, et al. Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism. Hypertens Res. 2021;44:1557\u201367.","journal-title":"Hypertens Res"},{"key":"2832_CR30","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"},{"key":"2832_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinforma. 2011;12:323.","journal-title":"BMC Bioinforma"},{"key":"2832_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139.","journal-title":"Nat Methods"},{"key":"2832_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"2832_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2513222123","volume":"123","author":"K Ishizawa","year":"2026","unstructured":"Ishizawa K, Kaseda K, Fujii W, Tomomitsu Y, Hirohama D, Yamazaki O, et al. Piezo1 dictates K(+) homeostasis through coordinated regulation of the ubiquitin ligase Kelch-like 3 in RBCs and the kidney. Proc Natl Acad Sci USA. 2026;123:e2513222123.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2832_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1681\/ASN.2017030243","volume":"29","author":"D Hirohama","year":"2018","unstructured":"Hirohama D, Ayuzawa N, Ueda K, Nishimoto M, Kawarazaki W, Watanabe A, et al. Aldosterone is essential for angiotensin II-induced upregulation of pendrin. J Am Soc Nephrol. 2018;29:57\u201368.","journal-title":"J Am Soc Nephrol"},{"key":"2832_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 2008;9:559.","journal-title":"BMC Bioinforma"},{"key":"2832_CR37","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.0000000000000141","volume":"34","author":"D Hirohama","year":"2023","unstructured":"Hirohama D, Abedini A, Moon S, Surapaneni A, Dillon ST, Vassalotti A, et al. Unbiased human kidney tissue proteomics identifies matrix metalloproteinase 7 as a kidney disease biomarker. J Am Soc Nephrol. 2023;34:1279\u201391.","journal-title":"J Am Soc Nephrol"},{"key":"2832_CR38","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216\u2013w21.","journal-title":"Nucleic Acids Res"},{"key":"2832_CR39","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353\u2013d61.","journal-title":"Nucleic Acids Res"},{"key":"2832_CR40","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504.","journal-title":"Genome Res"},{"key":"2832_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-4-2","volume":"4","author":"GD Bader","year":"2003","unstructured":"Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinforma. 2003;4:2.","journal-title":"BMC Bioinforma"},{"key":"2832_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41588-018-0302-x","volume":"51","author":"JA Morris","year":"2019","unstructured":"Morris JA, Kemp JP, Youlten SE, Laurent L, Logan JG, Chai RC, et al. An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet. 2019;51:258\u201366.","journal-title":"Nat Genet"},{"key":"2832_CR43","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1093\/eurheartj\/ehaf316","volume":"46","author":"M Berger","year":"2025","unstructured":"Berger M, MacNamara A, Ferreira JP, Kolkhof P, Voss S, Skubala A, et al. Finerenone effects on biomarkers: an analysis from the FIGARO-DKD trial. Eur Heart J. 2025;46:3382\u20136.","journal-title":"Eur Heart J"},{"key":"2832_CR44","doi-asserted-by":"publisher","first-page":"F1337","DOI":"10.1152\/ajprenal.00273.2015","volume":"310","author":"MB Moor","year":"2016","unstructured":"Moor MB, Bonny O. Ways of calcium reabsorption in the kidney. Am J Physiol Ren Physiol. 2016;310:F1337\u201350.","journal-title":"Am J Physiol Ren Physiol"},{"key":"2832_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/ndt\/gfae204","volume":"40","author":"AL Deluque","year":"2025","unstructured":"Deluque AL, Dimke H, Alexander RT. Biology of calcium homeostasis regulation in intestine and kidney. Nephrol Dial Transpl. 2025;40:435\u201345.","journal-title":"Nephrol Dial Transpl"},{"key":"2832_CR46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension. 2007;49:355\u201364.","journal-title":"Hypertension"},{"key":"2832_CR47","doi-asserted-by":"crossref","unstructured":"N\u00e1ray-Fejes-T\u00f3th A, Canessa C, Cleaveland ES, Aldrich G, Fejes-T\u00f3th G. sgk is an aldosterone-induced kinase in the renal collecting duct. J Biol Chem. 1999;274:16973\u20138.","DOI":"10.1074\/jbc.274.24.16973"},{"key":"2832_CR48","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1210\/endrev\/bnac031","volume":"44","author":"M Schini","year":"2023","unstructured":"Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone turnover markers: basic biology to clinical applications. Endocr Rev. 2023;44:417\u201373.","journal-title":"Endocr Rev"},{"key":"2832_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","volume":"447","author":"T Fumoto","year":"2014","unstructured":"Fumoto T, Ishii KA, Ito M, Berger S, Sch\u00fctz G, Ikeda K. Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia. Biochem Biophys Res Commun. 2014;447:407\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"2832_CR50","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/HJH.0b013e32834f0451","volume":"30","author":"C Maniero","year":"2012","unstructured":"Maniero C, Fassina A, Seccia TM, Toniato A, Iacobone M, Plebani M, et al. Mild hyperparathyroidism: a novel surgically correctable feature of primary aldosteronism. J Hypertens. 2012;30:390\u20135.","journal-title":"J Hypertens"},{"key":"2832_CR51","doi-asserted-by":"publisher","first-page":"e3694","DOI":"10.1210\/clinem\/dgaf151","volume":"110","author":"A Ooi","year":"2025","unstructured":"Ooi A, Khan H, Akram M, Fuller PJ, Milat F, Yang J, et al. Changes in PTH Across the Spectrum of Renin-independent Aldosteronism. J Clin Endocrinol Metab. 2025;110:e3694\u2013e700.","journal-title":"J Clin Endocrinol Metab"},{"key":"2832_CR52","doi-asserted-by":"crossref","unstructured":"Yoon SH, Meyer MB, Arevalo C, Tekguc M, Zhang C, Wang JS, et al. A parathyroid hormone\/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis. J Clin Invest. 2023;133:e163627.","DOI":"10.1172\/JCI163627"},{"key":"2832_CR53","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1681\/ASN.2011080865","volume":"22","author":"G Bhave","year":"2011","unstructured":"Bhave G, Neilson EG. Body fluid dynamics: back to the future. J Am Soc Nephrol. 2011;22:2166\u201381.","journal-title":"J Am Soc Nephrol"},{"key":"2832_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","volume":"15","author":"A Machnik","year":"2009","unstructured":"Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, Machura K, et al. Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med. 2009;15:545\u201352.","journal-title":"Nat Med"},{"key":"2832_CR55","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1172\/JCI60113","volume":"123","author":"H Wiig","year":"2013","unstructured":"Wiig H, Schr\u00f6der A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, et al. Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest. 2013;123:2803\u201315.","journal-title":"J Clin Invest"},{"key":"2832_CR56","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1161\/HYPERTENSIONAHA.123.20700","volume":"81","author":"K Kitada","year":"2024","unstructured":"Kitada K, Nishiyama A. Potential role of the skin in hypertension risk through water conservation. Hypertension. 2024;81:468\u201375.","journal-title":"Hypertension"},{"key":"2832_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60041-8","volume":"16","author":"S Taguchi","year":"2025","unstructured":"Taguchi S, Azushima K, Kitada K, Morisawa N, Kidoguchi S, Morita R, et al. Keratinocyte-specific angiotensin II receptor-associated protein deficiency exacerbates angiotensin II-dependent hypertension via activation of the skin renin-angiotensin system. Nat Commun. 2025;16:4789.","journal-title":"Nat Commun"},{"key":"2832_CR58","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s00424-014-1658-0","volume":"467","author":"JW Funder","year":"2015","unstructured":"Funder JW. Primary aldosteronism and salt. Pflug Arch. 2015;467:587\u201394.","journal-title":"Pflug Arch"},{"key":"2832_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/a-2172-7228","volume":"56","author":"L Chen","year":"2024","unstructured":"Chen L, Adolf C, Reincke M, Schneider H. Salt and Aldosterone - Reciprocal and Combined Effects in Preclinical Models and Humans. Horm Metab Res. 2024;56:99\u2013106.","journal-title":"Horm Metab Res"},{"key":"2832_CR60","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17:1726\u201333.","journal-title":"Osteoporos Int"},{"key":"2832_CR61","unstructured":"The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330."},{"key":"2832_CR62","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","volume":"581","author":"X Han","year":"2020","unstructured":"Han X, Zhou Z, Fei L, Sun H, Wang R, Chen Y, et al. Construction of a human cell landscape at single-cell level. Nature. 2020;581:303\u20139.","journal-title":"Nature"},{"key":"2832_CR63","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1038\/s41591-025-03872-8","volume":"31","author":"D Hirohama","year":"2025","unstructured":"Hirohama D, Fadista J, Ha E, Liu H, Abedini A, Levinsohn J, et al. The proteogenomic landscape of the human kidney and implications for cardio-kidney-metabolic health. Nat Med. 2025;31:3917\u201329.","journal-title":"Nat Med"},{"key":"2832_CR64","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1152\/physiolgenomics.00084.2017","volume":"50","author":"SB Poulsen","year":"2018","unstructured":"Poulsen SB, Limbutara K, Fenton RA, Pisitkun T, Christensen BM. RNA sequencing of kidney distal tubule cells reveals multiple mediators of chronic aldosterone action. Physiol Genomics. 2018;50:343\u201354.","journal-title":"Physiol Genomics"},{"key":"2832_CR65","doi-asserted-by":"crossref","unstructured":"Abedini A, S\u00e1nchez-Navaro A, Wu J, Kl\u00f6tzer KA, Ma Z, Poudel B, et al. Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists. J Clin Invest. 2024;134:e157165.","DOI":"10.1172\/JCI157165"},{"key":"2832_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09860-0","volume":"10","author":"U Styrkarsdottir","year":"2019","unstructured":"Styrkarsdottir U, Stefansson OA, Gunnarsdottir K, Thorleifsson G, Lund SH, Stefansdottir L, et al. GWAS of bone size yields twelve loci that also affect height, BMD, osteoarthritis or fractures. Nat Commun. 2019;10:2054.","journal-title":"Nat Commun"},{"key":"2832_CR67","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/jcp.25040","volume":"230","author":"E Mavrogonatou","year":"2015","unstructured":"Mavrogonatou E, Papadimitriou K, Urban JP, Papadopoulos V, Kletsas D. Deficiency in the \u03b11 subunit of Na+\/K+-ATPase enhances the anti-proliferative effect of high osmolality in nucleus pulposus intervertebral disc cells. J Cell Physiol. 2015;230:3037\u201348.","journal-title":"J Cell Physiol"},{"key":"2832_CR68","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1083\/jcb.200312135","volume":"164","author":"R Dacquin","year":"2004","unstructured":"Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, et al. Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol. 2004;164:509\u201314.","journal-title":"J Cell Biol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02832-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02832-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02832-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:02:12Z","timestamp":1790992932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02832-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":68,"alternative-id":["2832"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02832-0","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Esaxerenone was provided by Daiichi Sankyo. SS received honoraria from AstraZeneca, Bayer, Boehringer-Ingelheim, and Daiichi Sankyo outside the submitted work. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}